Nano-Mg(OH)2-induced proliferation inhibition and dysfunction of human umbilical vein vascular endothelial cells through caveolin-1-mediated endocytosis

Cell Biology and Toxicology

Volumn 31, Issue 1, 2015, Pages 15-27

  Meng, Ning ^a,b   Han, Lei ^a   Pan, XiaoHong ^c   Su, Le ^a   Jiang, Zheng ^a   Lin, Zhang ^a   Zhao, Jing ^a   Zhang, ShangLi ^a   Zhang, Yun ^d   Zhao, BaoXiang ^a   Miao, JunYing ^a,d  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF JINAN   (China)

^c FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Caveolin 1; Cytotoxicity; eNOS; HUVEC; Nano Mg(OH)2

Indexed keywords

CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MAGNESIUM OXIDE; NANOPARTICLE; NITRIC OXIDE; MAGNESIUM HYDROXIDE; METAL NANOPARTICLE; NOS3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL VEIN; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; CELL CULTURE; CELL SHAPE; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

CAVEOLIN 1; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; ENDOCYTOSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAGNESIUM HYDROXIDE; METAL NANOPARTICLES; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84924968824     PISSN: 07422091     EISSN: 15736822     Source Type: Journal    
DOI: 10.1007/s10565-014-9291-4     Document Type: Article

References (54)

1. Altman R, Rutledge JC. The vascular contribution to Alzheimer’s disease. Clin Sci (Lond). 2010;119:407–21.
2. Atochin DN, Huang PL. Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pflugers Arch. 2010;460:965–74.
3. Bai N et al. The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction. Pharmacol Ther. 2007;113:16–29.
4. Bakar AM et al. Isoflurane protects against human endothelial cell apoptosis by inducing sphingosine kinase-1 via ERK MAPK. Int J Mol Sci. 2012;13:977–93.
5. Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacol Rep. 2008;60:119–26.
6. Bucci M et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med. 2000;6:1362–7.
7. Cao Q et al. A study of the potential application of nano-Mg(OH)2 in adsorbing low concentrations of uranyl tricarbonate from water. Nanoscale. 2012;4:2423–30.
8. Chen WL et al. A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. Biochem Pharmacol. 2009;78:941–50.
9. Cheng C et al. Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells. Biomaterials. 2009;30:4152–60.
10. Cokakli M et al. Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion. BMC Cancer. 2009;9:65.
11. Donnini D et al. A new model of human aortic endothelial cells in vitro. Biochimie. 2000;82:1107–14.
12. Duan J et al. Silica nanoparticles induce autophagy and endothelial dysfunction via the PI3K/Akt/mTOR signaling pathway. Int J Nanomedicine. 2014;9:5131–41.
13. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983–92.
14. Fleissner F, Thum T. Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid Redox Signal. 2011;15:933–48.
15. Gao B-Y et al. Color removal from dye-containing wastewater by magnesium chloride. J Environ Manag. 2007;82:167–72.
16. Gao N et al. Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFkappaB activation and reduces its immunotoxicity. ACS Nano. 2011;5:4581–91.
17. Gong Q-H et al. Protective effects of Ginkgo biloba leaf extract on aluminum-induced brain dysfunction in rats. Life Sci. 2005;77:140–8.
18. Hirase T, Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol. 2012;302:H499–505.
19. Humplik T et al. Nanostructured materials for water desalination. Nanotechnology. 2011;22:292001.
20. Ioakeimidis N et al. Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction. Eur Urol. 2011;59:948–55.
21. Jaffe EA et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Investig. 1973;52:2745–56.
22. Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:998–1005.
23. Lee J et al. Caveolae-mediated endocytosis of conjugated polymer nanoparticles. Macromol Biosci. 2013;13:913–20.
24. Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 2000;190:244–54.
25. Liu W et al. Recycling Mg (OH) 2 nanoadsorbent during treating the low concentration of CrVI. Environ Sci Technol. 2011;45:1955–61.
26. Majkova Z et al. The role of caveolae in endothelial cell dysfunction with a focus on nutrition and environmental toxicants. J Cell Mol Med. 2010;14:2359–70.
27. Michel T, Vanhoutte PM. Cellular signaling and NO production. Pflugers Arch. 2010;459:807–16.
28. Mineo C, Shaul PW. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc Res. 2006;70:31–41.
29. Mu Q et al. Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. Nano Lett. 2009;9:4370–5.
30. Mudau M et al. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 2012;23:222–31.
31. Murdaca G et al. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis. 2012;224:309–17.
32. Oesterling E et al. Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol Lett. 2008;178:160–6.
33. Pan X et al. Investigation of antibacterial activity and related mechanism of a series of nano-Mg(OH)(2). ACS Appl Mater Interfaces. 2013;5:1137–42.
34. Peters K et al. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J Mater Sci Mater Med. 2004;15:321–5.
35. Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med. 1998;105:32S–9S.
36. Rafikov R et al. eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol. 2011;210:271–84.
37. Rahman A, Sward K. The role of caveolin-1 in cardiovascular regulation. Acta Physiol (Oxf). 2009;195:231–45.
38. Ramos-Cabrer P, Campos F. Liposomes and nanotechnology in drug development: focus on neurological targets. Int J Nanomedicine. 2013;8:951–60.
39. Reuel NF et al. Nanoengineered glycan sensors enabling native glycoprofiling for medicinal applications: towards profiling glycoproteins without labeling or liberation steps. Chem Soc Rev. 2012;41:5744–79.
40. Rochette L et al. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther. 2013;140:239–57.
41. Salmina AB et al. Endothelial dysfunction and repair in Alzheimer-type neurodegeneration: neuronal and glial control. J Alzheimers Dis. 2010;22:17–36.
42. Santoro D et al. Endothelial dysfunction in chronic renal failure. J Ren Nutr. 2010;20:S103–8.
43. Schlag S, et al. Stanford Research Institute Magnesium oxide and other magnesium chemicals Chemical Economics Handbook, CA; 2007
44. Smedlund K et al. On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease. Cardiovasc Hematol Agents Med Chem. 2012;10:265–74.
45. Sowa G. Caveolae, caveolins, cavins, and endothelial cell function: new insights. Front Physiol. 2012;2:120.
46. Su L et al. The effect of novel magnetic nanoparticles on vascular endothelial cell function in vitro and in vivo. J Hazard Mater. 2012;235–236:316–25.
47. Vesterdal LK et al. Pulmonary exposure to carbon black nanoparticles and vascular effects. Part Fibre Toxicol. 2010;7:33.
48. Voyta JC et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol. 1984;99:2034–40.
49. Wang Z, Malik AB. Nanoparticles squeezing across the blood-endothelial barrier via caveolae. Ther Deliv. 2013;4:131–3.
50. Wharton J et al. Dissociation of insulin receptor expression and signaling from caveolin-1 expression. J Biol Chem. 2005;280:13483–6.
51. Xia T et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2:2121–34.
52. Xu Y et al. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease. Eur J Pharmacol. 2008;585:256–60.
53. Zhang R et al. Cell rescue by nanosequestration: reduced cytotoxicity of an environmental remediation residue, Mg(OH)2 nanoflake/Cr(VI) adduct. Environ Sci Technol. 2014;48:1984–92.
54. Zhu MT et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett. 2011;203:162–71.